Financial Information | Regeneron Pharmaceuticals Inc.

Filing date	Form	Description	View
Jun 28, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000035.pdf 0001237899-04-000035.xls
Jun 21, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000032.pdf 0001237899-04-000032.xls
May 19, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000031.pdf 0001237899-04-000031.xls
May 06, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001237899-04-000029.pdf 0001237899-04-000029.xls
May 06, 2004	10-Q	Quarterly report which provides a continuing view of a company's financial position	View HTML 0000950123-04-005871.pdf 0000950123-04-005871.xls
May 05, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001254560-04-000004.pdf 0001254560-04-000004.xls
May 05, 2004	4	Statement of changes in beneficial ownership of securities	View HTML 0001254560-04-000005.pdf 0001254560-04-000005.xls
May 05, 2004	SC 13G/A	An amendment to the SC 13G filing	View HTML 0001193125-04-079147.pdf 0001193125-04-079147.xls
Apr 29, 2004	424B3	Form of prospectus reflecting facts events constituting substantive change from last form	View HTML 0000950123-04-005343.pdf 0000950123-04-005343.xls
Apr 28, 2004	8-K	Report of unscheduled material events or corporate event	View HTML 0000950123-04-005322.pdf 0000950123-04-005322.xls

Data provided by Kaleidoscope.

Investors & Media